Johnson KM

References (4)

Title : A Novel, Modified Human Butyrylcholinesterase Catalytically Degrades the Chemical Warfare Nerve Agent, Sarin - McGarry_2020_Toxicol.Sci_174_133
Author(s) : McGarry KG , Lalisse RF , Moyer RA , Johnson KM , Tallan AM , Winters TP , Taris JE , McElroy CA , Lemmon EE , Shafaat HS , Fan Y , Deal A , Marguet SC , Harvilchuck JA , Hadad CM , Wood DW
Ref : Toxicol Sci , 174 :133 , 2020
PubMedID: 31879758

Title : Dutogliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus - Johnson_2010_Curr.Opin.Investig.Drugs_11_455
Author(s) : Johnson KM
Ref : Curr Opin Investig Drugs , 11 :455 , 2010
PubMedID: 20336594

Title : Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog - Edgerton_2009_Diabetes_58_243
Author(s) : Edgerton DS , Johnson KM , Neal DW , Scott M , Hobbs CH , Zhang X , Duttaroy A , Cherrington AD
Ref : Diabetes , 58 :243 , 2009
PubMedID: 18840785

Title : Phencyclidine-induced inhibition of striatal acetylcholine release: comparisons with mu, kappa, and sigma opiate agonists - Leventer_1984_Life.Sci_34_793
Author(s) : Leventer SM , Johnson KM
Ref : Life Sciences , 34 :793 , 1984
PubMedID: 6366418